Germany reviews AstraZeneca vaccine after partial suspension in Berlin

Germany re-evaluates the covid-19 vaccine of AstraZeneca Plc, after the capital Berlin suspended its use for people under the age of 60 due to new data on potentially dangerous side effects.

Dilek Kalayci, the city’s top health official, said the German Independent Vaccine Committee STIKO – which is supported by the RKI Public Health Institute – and the Federal Vaccine Institute will do so. new recommendations on how to proceed. These could be released on Tuesday.

This is yet another blow to the AstraZeneca vaccine and another threat to the countryside inoculation of Europe. Germany and other European countries temporarily suspended administration of this vaccine earlier this month before resuming use after The European Union said it was safe.

German regional health ministers will also discuss the vaccine with federal government officials at a special meeting on Tuesday. RKI spokeswoman Susanne Glasmacher confirmed that the vaccines committee is evaluating the latest dosage information.

“We have to wait for the recommendations, but we wanted to take this step as a precaution,” Kalayci said at a press conference, adding that pending appointments will be canceled. “This vaccine prevents severe symptoms, and it’s very valuable, but we have to be careful “added.